Increased use of CTMS for Phase IV Trials and Epidemiology

One of the key emerging trends in the global pharmaceutical industry over the recent years is the rising number of post-marketing studies or Phase IV studies. In fact predictions are that the Global CTMS Market will grow to almost 2 Billion Dollars by 2017. As many as 75% of drugs that received approval during the […]

DZS, CTMS joins Medidata Rave® EDC Technology Partner Program

    Medidata Solutions Reports Record Fourth Quarter and Full Year 2010 Results — Clinical technology innovators continue to join the Medidata Technology Program, which now includes 12 partners, expanding the ability of customers to integrate additional applications with Medidata offerings. New technology partners in the fourth quarter include Logos Technologies, a provider of solutions […]

New Drug Approvals (NDAs) Slipped in 2010…Safety Job #1

Interesting WSJ article Some Potential Blockbusters Suffered Delays Amid FDA’s Tougher Safety Stance By JENNIFER CORBETT DOOREN WASHINGTON—The Food and Drug Administration approved about 21 drugs in 2010, a relatively modest figure that shows the pharmaceutical industry hasn’t yet escaped its drought in recent years. A few potential blockbusters won approval during the year, but […]